Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 109

1.

A role for SKIP in EBNA2 activation of CBF1-repressed promoters.

Zhou S, Fujimuro M, Hsieh JJ, Chen L, Hayward SD.

J Virol. 2000 Feb;74(4):1939-47.

2.

SKIP, a CBF1-associated protein, interacts with the ankyrin repeat domain of NotchIC To facilitate NotchIC function.

Zhou S, Fujimuro M, Hsieh JJ, Chen L, Miyamoto A, Weinmaster G, Hayward SD.

Mol Cell Biol. 2000 Apr;20(7):2400-10.

4.
5.

CIR, a corepressor linking the DNA binding factor CBF1 to the histone deacetylase complex.

Hsieh JJ, Zhou S, Chen L, Young DB, Hayward SD.

Proc Natl Acad Sci U S A. 1999 Jan 5;96(1):23-8.

6.

Masking of the CBF1/RBPJ kappa transcriptional repression domain by Epstein-Barr virus EBNA2.

Hsieh JJ, Hayward SD.

Science. 1995 Apr 28;268(5210):560-3.

PMID:
7725102
7.

Regulation of the Epstein-Barr virus C promoter by AUF1 and the cyclic AMP/protein kinase A signaling pathway.

Fuentes-Pananá EM, Peng R, Brewer G, Tan J, Ling PD.

J Virol. 2000 Sep;74(17):8166-75.

8.

Epstein-Barr virus nuclear antigen 3C interacts with histone deacetylase to repress transcription.

Radkov SA, Touitou R, Brehm A, Rowe M, West M, Kouzarides T, Allday MJ.

J Virol. 1999 Jul;73(7):5688-97.

9.

Truncated mammalian Notch1 activates CBF1/RBPJk-repressed genes by a mechanism resembling that of Epstein-Barr virus EBNA2.

Hsieh JJ, Henkel T, Salmon P, Robey E, Peterson MG, Hayward SD.

Mol Cell Biol. 1996 Mar;16(3):952-9.

10.

Mediation of Epstein-Barr virus EBNA2 transactivation by recombination signal-binding protein J kappa.

Henkel T, Ling PD, Hayward SD, Peterson MG.

Science. 1994 Jul 1;265(5168):92-5.

PMID:
8016657
11.
12.

Epstein-Barr virus immortalization: Notch2 interacts with CBF1 and blocks differentiation.

Hsieh JJ, Nofziger DE, Weinmaster G, Hayward SD.

J Virol. 1997 Mar;71(3):1938-45.

13.

Epstein-Barr virus nuclear antigen 2 trans-activates the cellular antiapoptotic bfl-1 gene by a CBF1/RBPJ kappa-dependent pathway.

Pegman PM, Smith SM, D'Souza BN, Loughran ST, Maier S, Kempkes B, Cahill PA, Simmons MJ, Gélinas C, Walls D.

J Virol. 2006 Aug;80(16):8133-44.

14.
16.
18.

Inhibition of Epstein-Barr virus-induced growth proliferation by a nuclear antigen EBNA2-TAT peptide.

Farrell CJ, Lee JM, Shin EC, Cebrat M, Cole PA, Hayward SD.

Proc Natl Acad Sci U S A. 2004 Mar 30;101(13):4625-30. Epub 2004 Mar 19. Erratum in: Proc Natl Acad Sci U S A. 2004 Sep 14;101(37):13694.

19.

Both Epstein-Barr viral nuclear antigen 2 (EBNA2) and activated Notch1 transactivate genes by interacting with the cellular protein RBP-J kappa.

Strobl LJ, Höfelmayr H, Stein C, Marschall G, Brielmeier M, Laux G, Bornkamm GW, Zimber-Strobl U.

Immunobiology. 1997 Dec;198(1-3):299-306. Review.

PMID:
9442401
20.

The NP9 protein encoded by the human endogenous retrovirus HERV-K(HML-2) negatively regulates gene activation of the Epstein-Barr virus nuclear antigen 2 (EBNA2).

Gross H, Barth S, Pfuhl T, Willnecker V, Spurk A, Gurtsevitch V, Sauter M, Hu B, Noessner E, Mueller-Lantzsch N, Kremmer E, Grässer FA.

Int J Cancer. 2011 Sep 1;129(5):1105-15. doi: 10.1002/ijc.25760. Epub 2011 Jan 12.

Supplemental Content

Support Center